NEW YORK, June 25, 2018 /PRNewswire/ --
Global Human Platelet Lysate Market to be Driven by Increased Funding andRise in Research Centers Across the Globe
According to a new study published by Persistence Market Research (PMR), the global human platelet lysate market is estimated to be valued at US$ 45.8 Mn in 2018 and
(Logo: https://mma.prnewswire.com/media/661339/Persistence_Market_Research.jpg )
Increased emphasis on funding and rise in research centers, product innovation, clinical and staff efficiency, government regulations and user acceptance are the major driving factors fueling the growth of the human platelet lysate market during the forecast period. Growing awareness levels of blood donation and adoption of advanced blood collection and processing technology in emerging countries is also expected to boost the human platelet lysate market.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/16789
In addition, a large donated blood pool in most of the developed countries is expected to fuel the demand for human platelet lysate (HPL) products over the forecast period. HPL are a convenient alternative to Fetal Bovine Serum (FBS) as an in-vitro cell culture growth supplement and are likely to be adopted extensively in the near future for various therapeutic applications. Moreover, human platelet lysate has emerged as a boom for cell manufacturing in cell- based therapeutics. Further, the rising demand for animal free serum media is anticipated to boost revenue growth of the Human Platelet Lysate market during the forecast period.
The global human platelet lysate market has been segmented on the basis of product, application, end user and region. Globally, Heparin-free Platelet Lysate and Platelet Lysate with Heparin both show lucrative market attractiveness. The Heparin-free Platelet Lysate segment is expected to be slightly more lucrative and is estimated to contribute 50.8% value share in the global human platelet lysate market during the forecast period.
Request For TOC @ https://www.persistencemarketresearch.com/methodology/16789
Among all end users of Human Platelet Lysate products, research and academic institutes are expected to be the most lucrative, given the increasing acceptance of Human Platelet Lysate products by the research fraternity. With nearly 37.7% market share, North America dominated the global Human Platelet Lysate market in 2017, partly due to increasing research and development activities, particularly stem cell and biopharmaceuticals especially in the United States.
Key Research Findings
Human Platelet Lysate Market Research Report Overview @ https://www.persistencemarketresearch.com/market-research/human-platelet-lysate-market.asp
Get full Report Now https://www.persistencemarketresearch.com/checkout/16789
Persistence Market Research Overview
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact: Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: +800-961-0353 Email: email@example.com
PMR Latest News: https://www.persistencemarketresearch.com/news
SOURCE Persistence Market Research Pvt. Ltd.
Subscribe to our Free Newsletters!